Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
26-valent Pneumococcal Conjugate Vaccine in People Aged 2 Months and Older
NCT06703203Phase 2Completed
- Sponsor
- Zhifei Green Bamboo
- Start
- Jul 2025
- Primary completion
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 26-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by Zhifei Green Bamboo. Started Jul 2025; status: completed.
02
Drugs
26-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT06703203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703203.